{"url_path":"/sec/aptn/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1938571/0001213900-26-057188-index.html","accession_number":"0001213900-26-057188","cik":"0001938571","ticker":"APTN","issuer_name":"ADAPTIN BIO, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1938571/0001213900-26-057188-index.html","primary_entity_key":"0001938571","primary_entity_name":"ADAPTIN BIO, INC."},"word_count":86,"has_tables":true,"body_markdown":"ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES\nAND USE OF PROCEEDS\n\n \n\nRecent Sales of Unregistered Securities\n\n \n\nIn the period covered by this Report, we completed\ntwo closings under our Follow-on Offering, issuing an aggregate of 130,400 shares of common stock to investors at $5.00 per share for\naggregate proceeds of $652,000. The transactions were exempt from registration under Section 4(a)(2) of the Securities Act, as not involving\nany public offering or Regulation D promulgated thereunder.\n\n \n\nPurchases of Equity Securities by the Issuer\nand Affiliated Purchasers\n\n \n\nNone."}